<DOC>
	<DOCNO>NCT00116155</DOCNO>
	<brief_summary>This multi-center , open-label , dose find study CV787 adenovirus patient hormone refractory metastatic prostate cancer . Patients receive treatment intravenously one nine dose level , contain three six patient .</brief_summary>
	<brief_title>Trial IV Injection CV787 Hormone Refractory Metastatic Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>None</criteria>
	<gender />
	<minimum_age />
	<maximum_age />
	<verification_date>June 2005</verification_date>
	<keyword>Hormone Refractory Metastatic Prostate Cancer</keyword>
</DOC>